Desmoplastic (sclerotic) nevus: An underrecognized entity that resembles dermatofibroma and desmoplastic melanoma

American Journal of Surgical Pathology

Volumn 23, Issue 7, 1999, Pages 786-794

  Harris, Geoffrey R ^a   Shea, Christopher R ^a   Horenstein, Marcelo G ^a   Reed, Jon A ^b   Burchette Jr , James L ^a   Prieto, Victor G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

CD34; Dermatofibroma; Desmoplastic melanoma; Desmoplastic nevus; Factor XIIIa; HMB 45; Hypopigmented blue nevus; Immunohistochemistry; Ki 67; Peripherin; S 100

Indexed keywords

BLOOD CLOTTING FACTOR 13A; COLLAGEN; KI 67 ANTIGEN; PERIPHERIN; PROTEIN S 100;

ADOLESCENT; ADULT; AGED; ARTICLE; BLUE NEVUS; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOLOGY; DENDRITIC CELL; DERMATOFIBROMA; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOLOGY; HUMAN; HYPERPIGMENTATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MELANOMA; NEVUS; NUCLEOLUS;

ADOLESCENT; ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; NEVUS; NEVUS, BLUE; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032983503     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199907000-00006     Document Type: Article

References (32)

1. Abenoza P, Lillemoe T. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am J Dermatopathol 1993;15:429-34.
2. Anstey A, Cerio R, Ramnarain N, Orchard G, Smith N, Jones EW. Desmoplastic malignant melanoma. Am J Dermatopathol 1994;16: 14-22.
3. Barnhill RL. Pathology and prognostic factors. Curr Opin Oncol 1993;5:364-76.
4. Barr RJ, Morales V, Graham JH. Desmoplastic nevus: a distinct histologic variant of mixed spindle cell and epithelioid cell nevus. Cancer 1980;46:557-64.
5. Carr S, See J, Wilkinson B, Kossard S. Hypopigmented common blue nevus. J Cutan Pathol 1997;24:494-8.
6. Cerio R, Spaull J, Jones EW. Histiocytoma cutis: a tumor of dermal dendrocytes (dermal dendrocytoma). Br J Dermatol 1989;120: 197-206.
7. Colombari R, Bonetti F, Zamboni G, et al. Distribution of melanoma specific antibody (HMB-45) in benign and malignant melanocytic tumours, an immunohistochemical study on paraffin sections. Virchows Archiv A Pathol Anat 1988;413:17-24.
8. Denton KJ, Cotton DW, Wright A, Hird P. Factor XIIIa in nodular malignant melanoma and Spitz naevi. Br J Dermatol 1990;123: 783-6.
9. Jain S, Allen PW. Desmoplastic malignant melanoma and its variants: a study of 45 cases. Am J Surg Pathol 1989;13:358-73.
10. Kaneishi NK, Cockerell CJ. Histologic differentiation of desmoplastic melanoma from cicatrices. Am J Dermatopathol 1998;20: 128-34.
11. Kanter L, Biegen H, Wejde J, Lagerlof B, Larsson O. Utility of a proliferation marker in distinguishing between benign naevocellular naevi and naevocellular naevus-like lesions with malignant properties. Melanoma Res 1995;5:345-50.
12. Longacre TA, Egbert BM, Rouse RV. Desmoplastic and spindle-cell malignant melanoma: an immunohistochemical study. Am J Surg Pathol 1996;20:1489-500.
13. Mackie RM, Doherty VR. The desmoplastic melanocytic naevus: a distinct histological entity. Histopathology 1992;20:207-11.
14. Maize JC, Foster G. Age-related changes in melanocytic naevi. Clin Exp Dermatol 1979;4:49-58.
15. McKee PH. Pathology of the skin with clinical correlations, 2nd ed. London: Mosby-Wolfe, 1996;13.17,13.18,16.23-16.25.
16. McNutt NS, Urmacher C, Hakimian J, Hoss DM, Lugo J. Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity. J Cutan Pathol 1995;22:502-17.
17. Michal M, Kerekes Z, Kinkor Z, Ondrias F. Pizinger K. Desmoplastic cellular blue nevi. Am J Dermatopathol 1995;17:230-5.
18. Paniago-Pereira C, Maize JC, Ackerman AB. Nevus of large spindle and/or epithelioid cells (Spitz's nevus). Arch Dermatol 1978;114:1811-23.
19. Perniciaro C. Dermatopathologic variants of malignant melanoma. Mayo Clin Proc 1997;72:273-9.
20. Prieto VG, McNutt NS, Lugo J, Reed JA. Differential expression of the intermediate filament peripherin in cutaneous neural lesions and neurotized melanocytic nevi. Am J Surg Pathol 1997;21: 1450-4.
21. Prieto VG, Reed JA, Shea CR. Immunohistochemistry of dermatofibromas and benign fibrous histiocytomas. J Cutan Pathol 1995; 22:336-41.
22. Reed JA, Manahan LJ, Park CS, Brigatti DJ. Complete one-hour immunocytochemistry based on capillary action. Biotechniques 1992;13:434-43.
23. Reed RJ, Ichinose H, Clark WH Jr, Mihm MC Jr. Common and uncommon melanocytic nevi and borderline melanomas. Semin Oncol 1975;2:119-47.
24. Sagebiel RW. Who needs zebras? Comments on desmoplastic melanoma. J Am Acad Dermatol 1995;32:800-2.
25. Schoenfeld RJ. Epidermal proliferations overlying histiocytomas. Arch Derm 1964;90:266-70.
26. Skelton HG III, Smith KJ, Barrett TL, Lupton GP, Graham JH. HMB-45 staining in benign and malignant melanocytic lesions. Am J Dermatopathol 1991;13:543-50.
27. Skelton HG III, Smith KJ, Laskin WB, et al. Desmoplastic malignant melanoma. J Am Acad Dermatol 1995;32:717-25.
28. Smolle J, Hans-Peter S, Kerl H. Proliferative activity of cutaneous melanocytic tumors defined by Ki-67 monoclonal antibody: a quantitative immunohistochemical study. Am J Dermatopathol 1989;11:301-7.
29. Sparrow LE, English DR, Taran JM, Heenan PJ. Prognostic significance of MIB-1 proliferative activity in thin melanomas and immunohistochemical analysis of MIB-1 proliferative activity in melanocytic tumors. Am J Dermatopathol 1998;20:12-6.
30. Walsh NMG, Roberts JT, Orr W, Simon GT. Desmoplastic malignant melanoma. Arch Pathol Lab Med 1988:112:922-7.
31. Weinzweig N, Tuthill RJ, Yetman RJ. Desmoplastic malignant melanoma: a clinicohistopathologic review. Plast Reconstr Surg 1995;95:548-55.
32. Zelger BG, Steiner H, Wambacher B, Zeiger B. Malignant melanomas simulating various types of soft tissue tumors. Dermatol Surg 1997;23:1047-54.